var data={"title":"Bacitracin (systemic): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Bacitracin (systemic): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/722271?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=bacitracin-systemic-patient-drug-information\" class=\"drug drug_patient\">see &quot;Bacitracin (systemic): Patient drug information&quot;</a> and <a href=\"topic.htm?path=bacitracin-systemic-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Bacitracin (systemic): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147622\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Nephrotoxicity:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Bacitracin in parenteral (IM) therapy may cause renal failure due to tubular and glomerular necrosis. Its use should be restricted to infants with staphylococcal pneumonia and empyema when due to organisms shown to be susceptible to bacitracin. It should be used only where adequate laboratory facilities are available and when constant supervision of the patient is possible.</p>\n        <p style=\"text-indent:-2em;margin-left:2em;\">Renal function should be carefully determined prior to and daily during therapy. The recommended daily dose should not be exceeded, and fluid intake and urinary output should be maintained at proper levels to avoid kidney toxicity. If renal toxicity occurs the drug should be discontinued. The concurrent use of other nephrotoxic drugs, particularly streptomycin, kanamycin, polymyxin B, polymyxin E (colistin), and neomycin should be avoided.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147627\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>BACiiM</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26111381\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>BaciJect</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147630\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antibiotic, Miscellaneous</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147656\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=bacitracin-systemic-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Bacitracin (systemic): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Do not administer IV </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Treatment of pneumonia and empyema:</b> <i>Infants:</i> IM: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&le;2.5 kg: 900 units/kg/day in 2 to 3 divided doses </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&gt;2.5 kg: 1000 units/kg/day in 2 to 3 divided doses </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147672\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution Reconstituted, Intramuscular: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">BACiiM: 50,000 units (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 50,000 units (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution Reconstituted, Intramuscular [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 50,000 units (1 ea [DSC])</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147629\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147659\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">IM: For IM administration only, <b>do not administer IV</b>. Confirm any orders for parenteral use. Administer to upper outer quadrant of the buttocks; rotate administration site.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147634\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Pneumonia and empyema:</b> Treatment of pneumonia and empyema in infants caused by susceptible staphylococci; due to toxicity risks, systemic uses of bacitracin should be limited to situations where less toxic alternatives would not be effective</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147623\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Bacitracin may be confused with Bactrim, Bactroban</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147642\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Endocrine &amp; metabolic: Albuminuria</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gastrointestinal: Nausea, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Genitourinary: Azotemia, casts in urine, nephrotoxicity</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Pain at injection site</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Renal: Renal failure</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Postmarketing and/or case reports: Anaphylaxis (intraoperative exposure [Damm, 2011])</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147639\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to bacitracin or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147640\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Anaphylaxis: Use with caution in patients who have been previously exposed to bacitracin; anaphylactic reactions have occurred on repeat exposure especially with irrigation use (Damm 2011; Elsner 1990; Farley 1995).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal failure: <b>[US Boxed Warning]: IM use may cause renal failure due to tubular and glomerular necrosis; monitor renal function daily.</b> Avoid concurrent use with other nephrotoxic drugs; discontinue use if toxicity occurs; maintain adequate fluid intake and urine output throughout therapy. Do not exceed recommended doses.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: Do not administer intravenously because severe thrombophlebitis occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Monitoring: Should only be used when adequate laboratory facilities are available and constant patient supervision is available.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24574208\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24574205\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=97027&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Colistimethate: May enhance the nephrotoxic effect of Bacitracin (Systemic).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Kanamycin: May enhance the nephrotoxic effect of Bacitracin (Systemic).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neomycin: May enhance the nephrotoxic effect of Bacitracin (Systemic).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular-Blocking Agents: Bacitracin (Systemic) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Polymyxin B: May enhance the nephrotoxic effect of Bacitracin (Systemic).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Streptomycin: May enhance the nephrotoxic effect of Bacitracin (Systemic).<i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147636\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">This product is not indicated for use in women of reproductive age.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147638\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">This product is not indicated for use in women of reproductive age.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147663\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">IM: Urinalysis, renal function tests, urine output</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147645\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Inhibits bacterial cell wall synthesis by preventing transfer of mucopeptides into the growing cell wall</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147647\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Rapidly following IM administration </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Widely distributed in all body organs and is demonstrable in ascitic and pleural fluids after IM injection</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24147674\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (Bacitracin Intramuscular)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">50000 unit (1): $13.31</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    BACiiM (bacitracin) [prescribing information], Horseheads, NY: X-Gen Pharmaceuticals Inc; June 2008. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bacitracin (prescribing information). New York, NY: Pharmacia &amp; Upjohn; September 2015. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chia JK, Nakata MM, Park SS, et al, &ldquo;Use of Bacitracin Therapy for Infection Due to Vancomycin-Resistant <i>Enterococcus faecium</i>,&rdquo; <i>Clin Infect Dis</i>, 1995, 21(6):1520. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/8749657/pubmed\" target=\"_blank\" id=\"8749657\">8749657</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cohen SH, Gerding DN, Johnson S, et al, &ldquo;Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection in Adults: 2010 Update by the Society for healthcare Epidemiology of American (SHEA) and the Infectious Diseases Society of America (IDSA), <i>Infect Control Hosp Epidemiol</i>, 2010, 31(5):431-55.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/20307191/pubmed\" target=\"_blank\" id=\"20307191\">20307191</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Damm S. Intraoperative anaphylaxis associated with bacitracin irrigation. <i>Am J Health-Syst Pharm</i>. 2011;68(4):323-327.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/21289327/pubmed\" target=\"_blank\" id=\"21289327\">21289327</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dudley MN, McLaughlin JC, Carrington G, et al, &ldquo;Oral Bacitracin vs Vancomycin Therapy for <i>Clostridium difficile</i>-Induced Diarrhea. A Randomized Double-Blind Trial,&rdquo; <i>Arch Intern Med</i>, 1986, 146(6):1101-4.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Elsner P, Pevny I, Burg G. Anaphylaxis induced by topically applied bacitracin. <i>Am J Contact Dermat</i>.1990;1:162-164.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Farley M, Pak H, Carregal V, Engler R, James W. Anaphylaxis to topically applied bacitracin. <i>Am J Contact Dermat</i>. 1995:6(1):28-31.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Katz BE and Fisher AA, &ldquo;Bacitracin: A Unique Topical Antibiotic Sensitizer,&rdquo; <i>J Am Acad Dermatol</i>, 1987, 17(6):1016-24. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/2963037/pubmed\" target=\"_blank\" id=\"2963037\">2963037</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kelly CP, Pothoulakis C, and LaMont JT, &ldquo;<i>Clostridium difficile</i> Colitis,&rdquo; <i>N Engl J Med</i>, 1994, 330(4):257-62. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/8043060/pubmed\" target=\"_blank\" id=\"8043060\">8043060</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mondy KE, Shannon W, and Mundy LM, &ldquo;Evaluation of Zinc Bacitracin Capsules Versus Placebo for Enteric Eradication of Vancomycin-Resistant <i>Enterococcus faecium</i>,&rdquo; <i>Clin Infect Dis</i>, 2001, 33(4):473-6. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/11462182/pubmed\" target=\"_blank\" id=\"11462182\">11462182</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, et al, &ldquo;Enteric Eradication of Vancomycin-Resistant <i>Enterococcus faecium</i> With Oral Bacitracin,&rdquo; <i>Diagn Microbiol Infect Dis</i>, 1994, 18(2):105-9. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/8062527/pubmed\" target=\"_blank\" id=\"8062527\">8062527</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vale MA, Connolly A, Epstein AM, et al, &ldquo;Bacitracin-Induced Anaphylaxis,&rdquo; <i>Arch Dermatol</i>, 1978, 114(5):800. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Westerman EL, &ldquo;Toxicity of Mediastinal Irrigation With Bacitracin,&rdquo; <i>JAMA</i>, 1983, 250(7):899. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Young GP, Ward PB, Bayley N, et al, &ldquo;Antibiotic-Associated Colitis Due to <i>Clostridium difficile</i>: Double-Blind Comparison of Vancomycin With Bacitracin,&rdquo; <i>Gastroenterology</i>, 1985, 89(5):1038-45.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/bacitracin-systemic-drug-information/abstract-text/4043661/pubmed\" target=\"_blank\" id=\"4043661\">4043661</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 97027 Version 38.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F24147622\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F24147627\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F26111381\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F24147630\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F24147656\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F24147672\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F24147629\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F24147659\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F24147634\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F24147623\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F24147642\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F24147639\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F24147640\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F24574208\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F24574205\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F24147636\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F24147638\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F24147663\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F24147645\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F24147647\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F24147674\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/97027|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=bacitracin-systemic-patient-drug-information\" class=\"drug drug_patient\">Bacitracin (systemic): Patient drug information</a></li><li><a href=\"topic.htm?path=bacitracin-systemic-pediatric-drug-information\" class=\"drug drug_pediatric\">Bacitracin (systemic): Pediatric drug information</a></li></ul></div></div>","javascript":null}